Drug profile
The FDA adverse-event record for Sebelipase Alfa Strength Indicated Is For Final Drug Product And Is Not Administered To The Animal.
16 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Sebelipase Alfa Strength Indicated Is For Final Drug Product And Is Not Administered To The Animal.. See the species affected, top reactions, and outcomes below.
- 16
- adverse-event reports
- 100.0%
- death-coded share
- Chicken
- most-reported species
- 16
- IGA Animal mortality greater than expected - top reaction
Active Ingredients
Administration Routes
Species Affected
Most Affected Breeds
Most Reported Reactions
Outcome Breakdown
Sebelipase Alfa Strength Indicated Is For Final Drug Product And Is Not Administered To The Animal. Adverse Event Insights
16 reports name Sebelipase Alfa Strength Indicated Is For Final Drug Product And Is Not Administered To The Animal.; 16 recorded a death outcome (100.0% of reported events, not a population-level mortality rate). Active ingredient: Sebelipase Alfa Strength Indicated Is For Final Drug Product And Is Not Administered To The Animal.. Administration route: Unknown.
By species: Chicken (15 reports), Chinchilla (1 reports). By breed: Unknown (16).
Leading clinical signs: IGA Animal mortality greater than expected (16), IGA Animal morbidity greater than expected (15), Found dead (3), Death (1). Outcome, 29 coded reports: Euthanized leads at 55.2%.
Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.
Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025
Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.